Macrophages are major cellular inhabitants of cycling and pregnant mammalian uteri. Their densities and patterns of tissue distribution in this organ fluctuate in concert with levels of circulating female sex steroid hormones, estrogens and progesterone, and their production of various effector molecules also may be hormonally regulated. Hormonal control may be achieved by direct binding to receptors or by indirect pathways where hormones modulate production of various autocrine and paracrine cytokines and growth factors that then target to resident macrophages and influence their secretory profiles. In this paper, we marshall evidence supporting the concept that progesterone acts as a powerful negative regulator of these versatile cells, reducing their migration into the uterus and impairing their ability to produce potent effector molecules such as nitric oxide that could interfere with the success of pregnancy.
INTRODUCTION
Although macrophages have long been recognized as major cellular inhabitants of cycling and pregnant mammalian uteri, nearly all of the studies that have established the fundamental characteristics of these remarkable cells have been reported within the last decade and a half (reviewed by Hunt, 1989; Hunt and Pollard, 1992) . Macrophage densities and distributional patterns within cycling and pregnant uteri of rodents and women have been mapped; conditions influencing their migration, differentiation, and activation in the uterus have been investigated; and some information on their secretory profiles has been generated. (Werb, 1978; Werb et al., 1978a Werb et al., , 1978b . Studies done recently in our laboratory where no additive effect over dexamethazone alone was obtained when macrophages were treated with a combination of progesterone plus dexamethazone tend to support the cross-binding interpretation. Our current experiments are directed toward learning whether the same types of intracellular signaling pathways such as activation of the transcription factor inhibitor, ItBc (Baeuerle and Henkel, 1994; Scheinman et al., 1995) , occur in progesterone-and glucocorticoid-treated mouse macrophages.
MACROPHAGE RECEPTORS FOR HORMONES AND CYTOKINES
The exquisite sensitivity of macrophages to environmental signals is due to the presence of a wide range of receptors for modulators such as steroid hormones, polypeptide growth factors, cytokines, and bioactive lipids.
Hormone Receptors
Several investigators have reported the presence of estrogen receptors on macrophages and this was recently verified in our laboratory by using reversetranscription polymerase chain reaction (RT-PCR) . The mouse macrophage cell lines, RAW264.7 and J774, as well as culture-derived mouse bone-marrow macrophages contained estrogen receptor (ER) mRNA. Macrophages also exhibit abundant receptors for glucocorticoids (GR) (Auger and Ross, 1992 ), but it is not entirely clear whether the cells express androgen receptors (reviewed by 
HORMONAL INFLUENCES ON MACROPHAGE MIGRATION
The mouse estrus cycle is characterized by an increase in the levels of circulating estrogen as the cycle progresses from proestrus to estrus, and an increase in the levels of circulating progesterone as the cycle continues into diestrus-I and diestrus-II (McCormack and Greenwald, 1974 ; reviewed by Hunt and Robertson, 1996) . Possibly, chemoattraction is achieved by MIP-lc, MIP-1/3, RANTES, or JE, all of which are transcribed in pregnant mouse uterus (Robertson et al., in press ). Specific message is present for all of these chemoattractants, but it is not yet known whether the transcripts are translated and functional proteins are produced.
The numbers of macrophages are dramatically reduced in diestrus-II and proestrus uteri, and the pregnancy-stimulated influx of macrophages appears to be halted during the middle stages of pregnancy. Because progesterone is high relative to estrogen during these stages, these observations are consistent with the idea that progesterone inhibits macrophage migration. This could be (1) a direct hormonal effect on the macrophage genes that promote migration such as receptors for certain adhesion molecules, (2) associated with reduction of uterine chemoattractants, or (3) due to enhanced expression of molecules such as Fas ligand that restrict migration of activated hematopoietic cells (Griffith et al., 1995 
IFN-T in Mouse Uterus
The question then arises as to whether or not IFN-y is present in cycling and/or pregnant mouse uterus. Lin et al. (1993) showed that IFN-y is detectable in early postimplantation mouse uteroplacental units by ELISA, and limited RT-PCR analyses conducted in our laboratory indicate that the IFN-y gene is transcribed at both early (day 6) and late (day 18) stages of mouse pregnancy (Platt and Hunt, 1996) .
The cellular source(s) of IFN-y are as yet unclear but might include uterine natural killer cells (uNK) . In other contexts, NK cells initiate immune responses with IFN-y production (Sheehan and Schreiber, 1992) . Alternatively, mouse placental trophoblast cells may produce IFN-y as is the case in the pig and human (LeFevre et al., 1990; Haynes et al., 1993) .
Interestingly and of potential relevance to pregnancy, the IFN-y gene itself is hormonally regulated; estrogen activates the IFN-y promoter (Fox et al., 1991) . Cause-and-effect 
HORMONAL REGULATION OF MACROPHAGE SECRETORY PROFILES
A limited number of observations point to regulation of uterine macrophage secretions by female hormones and/or the cytokines they control. The data collected thus far are consistent with the idea that progesterone programs uterine macrophages into a suppressive profile.
Studies Conducted In Vivo
Macrophages in pregnant mouse uterus are major sites of production of the anti-inflammatory, immunosuppressive lipid, prostaglandin E2 (PGE2) (Tawfik et al., 1986 ; reviewed by Hunt, 1992) . Two additional anti-inflammatory cytokines, transforming growth factor-/31 and interleukin-10 (IL-10), are produced in mouse and rat uterus Lin et al., 1993) In macrophages, NO is produced following activation of the inducible nitric oxide synthase (iNOS) gene. We tested the ability of estrogens and progesterone singly and in combination, dexamethazone (positive control) and neutral lipids (negative controls), as well as estrogen and progesterone analogs to influence activation of the iNOS gene promoter, steadystate levels of iNOS transcripts, and production of NO . These experiments utilized several strategies, including transient transfection of promoter constructs into RAW264.7 mouse macrophages and northern blots as well as substrate conversion assays in RAW264.7 cells, J774 cells, and cultured mouse bone-marrow macrophages.
The results of these studies showed clearly that despite the absence of detectable PR mRNA progesterone efficiently downregulates all three phases, that is, iNOS gene activation, accumulation of specific mRNA, and production of NO. This finding is consistent with a previous report from our laboratory, which demonstrated that progesterone downregulates iNOS in uterine mast cells (Huang et al., 1995) , as well as the observation that progesterone inhibits the ability of macrophages to kill target cells (Feinberg et al., 1992 
